Polynovo Ltd

AU:PNV Australia Medical Devices
Market Cap
$402.10 Million
AU$649.39 Million AUD
Market Cap Rank
#12081 Global
#144 in Australia
Share Price
AU$0.94
Change (1 day)
-1.57%
52-Week Range
AU$0.88 - AU$1.67
All Time High
AU$4.01
Categories
Companies in Australia Medical Devices
About

PolyNovo Limited designs, manufactures, and sells biodegradable medical devices in Australia, New Zealand, the United States, the United Kingdom, Ireland, Singapore, India, and Hong Kong. The company offers NovoSorb Biodegradable Temporising Matrix, a dermal matrix for the regeneration of the dermis when lost through extensive surgery, trauma, or burn. It is also developing hernia devices for her… Read more

Polynovo Ltd (PNV) - Cash Flow Conversion Efficiency

Latest cash flow conversion efficiency as of June 2025: 0.190x

Based on the latest financial reports, Polynovo Ltd (PNV) has a cash flow conversion efficiency ratio of 0.190x as of June 2025.

Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (AU$15.79 Million) by net assets (AU$83.26 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Polynovo Ltd - Cash Flow Conversion Efficiency Trend (1999–2025)

This chart illustrates how Polynovo Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.

Polynovo Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Polynovo Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Shanghai Yongli Belting Co Ltd
SHE:300230
 		0.037x
Hangzhou Raycloud Technology Co Ltd
SHG:688365
 		0.018x
Giti Tire Corp
SHG:600182
 		0.076x
SFA Semicon Co. Ltd
KQ:036540
 		-0.016x
Douglas AG
XETRA:DOU
 		0.436x
Zhejiang Tengen Electrics Co Ltd
SHG:605066
 		N/A
Zhejiang Chimin Pharm Co Ltd
SHG:603222
 		0.003x
Agora Inc
NASDAQ:API
 		0.017x

Annual Cash Flow Conversion Efficiency for Polynovo Ltd (1999–2025)

The table below shows the annual cash flow conversion efficiency of Polynovo Ltd from 1999 to 2025.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-06-30 AU$83.26 Million AU$3.15 Million 0.038x -25.96%
2024-06-30 AU$72.12 Million AU$3.68 Million 0.051x +156.27%
2023-06-30 AU$65.38 Million AU$-5.93 Million -0.091x +21.84%
2022-06-30 AU$17.72 Million AU$-2.06 Million -0.116x -943.25%
2021-06-30 AU$22.35 Million AU$-248.74K -0.011x +34.18%
2020-06-30 AU$23.81 Million AU$-402.56K -0.017x +86.91%
2019-06-30 AU$26.10 Million AU$-3.37 Million -0.129x +46.58%
2018-06-30 AU$28.46 Million AU$-6.88 Million -0.242x +49.37%
2017-06-30 AU$10.81 Million AU$-5.16 Million -0.477x -102.83%
2016-06-30 AU$15.11 Million AU$-3.56 Million -0.235x +32.23%
2015-06-30 AU$7.39 Million AU$-2.57 Million -0.347x -15.20%
2014-06-30 AU$8.67 Million AU$-2.61 Million -0.301x -1.32%
2013-06-30 AU$7.82 Million AU$-2.33 Million -0.298x +10.85%
2012-06-30 AU$7.99 Million AU$-2.67 Million -0.334x -21.19%
2011-06-30 AU$10.64 Million AU$-2.93 Million -0.275x -33.67%
2010-06-30 AU$13.74 Million AU$-2.83 Million -0.206x +4.61%
2009-06-30 AU$15.82 Million AU$-3.42 Million -0.216x +13.55%
2008-06-30 AU$16.46 Million AU$-4.11 Million -0.250x +61.32%
2007-06-30 AU$20.79 Million AU$-13.42 Million -0.646x -45.42%
2006-06-30 AU$22.76 Million AU$-10.11 Million -0.444x +27.96%
2005-06-30 AU$17.28 Million AU$-10.65 Million -0.616x -15.86%
2004-06-30 AU$16.68 Million AU$-8.88 Million -0.532x +57.46%
2003-06-30 AU$6.26 Million AU$-7.83 Million -1.251x -221.74%
2002-06-30 AU$12.15 Million AU$-4.72 Million -0.389x +47.32%
2001-06-30 AU$6.41 Million AU$-4.73 Million -0.738x -147.23%
2000-06-30 AU$11.46 Million AU$-3.42 Million -0.298x -46.78%
1999-06-30 AU$6.66 Million AU$-1.35 Million -0.203x --